Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Common Equity (2021 - 2025)

Historic Common Equity for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $8.2 million.

  • Cardio Diagnostics Holdings' Common Equity rose 12113.84% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 12113.84%. This contributed to the annual value of $9.6 million for FY2024, which is 22310.3% up from last year.
  • Cardio Diagnostics Holdings' Common Equity amounted to $8.2 million in Q3 2025, which was up 12113.84% from $9.7 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' 5-year Common Equity high stood at $11.4 million for Q1 2025, and its period low was $24279.0 during Q3 2021.
  • For the 5-year period, Cardio Diagnostics Holdings' Common Equity averaged around $4.8 million, with its median value being $3.2 million (2023).
  • In the last 5 years, Cardio Diagnostics Holdings' Common Equity surged by 3933739.79% in 2022 and then crashed by 7610.13% in 2023.
  • Quarter analysis of 5 years shows Cardio Diagnostics Holdings' Common Equity stood at $1.1 million in 2021, then soared by 302.74% to $4.3 million in 2022, then plummeted by 31.23% to $3.0 million in 2023, then surged by 223.1% to $9.6 million in 2024, then decreased by 14.71% to $8.2 million in 2025.
  • Its last three reported values are $8.2 million in Q3 2025, $9.7 million for Q2 2025, and $11.4 million during Q1 2025.